Which of the following is given to treat thrombocytopenia secondary to anticancer therapy and is known to stimulate progenitor megakaryocytes?: (A) Filgrastim, (B) Oprelvekin, (C) Erythropoietin, (D) Iron dextran
Answer is B. Oprelvekin (IL-11) is used to prevent and treat thrombocytopenia.